Metabolic syndrome (MetS) is closely associated with the development of cardiovascular
diseases. We recently developed a nano-preparation of the flavonoid quercetin (QU) in a …

Background Cardiovascular diseases are the most causes of mortality and morbidity among
diabetes mellitus (DM) patients. Electrocardiographic (ECG) changes are common in the …

Abstract Background Metabolic syndrome (MetS) known as a risk factor for cardiovascular
diseases (CVDs) has developed into a major source of health issue, especially for the …

Background Metabolic syndrome (MetS) is a prognostic cluster of physiologic risk factors
that may develop into cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) …

Aims To identify the prevalence of major and minor electrocardiographic abnormalities and
their association with the main risk factors for cardiovascular disease in a population in the …

Introduction This study evaluated the status of stage 2 hypertension, abnormal ECG and
their co-occurrence as possible risk factors of cardiovascular disease and their predictors in …

Abstract Review: Saudi Arabia has a high metabolic syndrome (MetS) prevalence. Having
MetS increases the risk of cardiovascular disease (CVD), CVD mortality, and myocardial …

Metabolic syndrome (MetS) is a cardiometabolic condition that may develop into
cardiovascular disease and type 2 diabetes mellitus. Early recognition and associated …

Background: Cardiovascular diseases are the most causes of mortality and morbidity among
diabetes mellitus (DM) patients. Electrocardiographic (ECG) changes are common in the …

Cardiovascular disease is now a leading cause of death globally. However, metabolic
syndrome is an extremely critical healthcare issue worldwide due to progressive increase in …